COVID-19 infection COVID-19, new coronavirus
Conditions
Interventions
blood adsorption therapy
apheresis, blood adsorption therapy
Sponsors
Isaka Yoshitaka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who show positive for nucleic acid of SARS-CoV-2 in the blood at the pre-enrollment test 2) Patients who need on artificial ventilator or ECMO 3) Patients who voluntarily give a written consent after receiving a thorough explanation and having an adequate understanding to be enrolled in the study 4) Patients whose age is 18 or elder when obtaining the consent . If the patient is under 20, the consent shuld be obtained from a legal representative such as a person in parental authority in addition to the patient itself.
Exclusion criteria
Exclusion criteria: 1) Patients whose circulatory dynamics is unstable and difficult to put on the adsorption therapy 2) Patients who are participating other interventional clinical studies 3) Patients who are pregnant or possibly pregnant or lactating 4) Patients judged by the principal investigator or subinvestigator inappropriate to be enrolled in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of the patients who were able to withdraw from the ventilator or ECMO | — |
Secondary
| Measure | Time frame |
|---|---|
| The ratio of the patients who turned negative for virus in the blood Improvement of respiratory function (PaO2/FiO2 ratio) | — |
Contacts
Public ContactYoshitaka Isaka
Osaka University Hospital
Outcome results
None listed